Selecky Christobel's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Jul 6, 2026
- Accession no.
- 0001849739-26-000014
- Filed
- Jul 6, 2026, 8:25 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.44M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Selecky ChristobelCIK 0001849739 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | MOption exerciseAcquired | +35,064 | $2.98 | +$104,490.72 | 35,064 | Direct | |
| Jul 1, 2026 | Common Stock | MOption exerciseAcquired | +124,414 | $2.99 | +$371,997.86 | 159,478 | Direct | |
| Jul 1, 2026 | Common Stock | SSaleDisposed | −159,478 | $9.02F2 | −$1,439,065.68 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | MOption exerciseDisposed | −35,064 | $0.00 | $0 | 0 | Direct | |
| Jul 1, 2026 | Common Stock | MOption exerciseDisposed | −124,414 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 159,478 shares sold in the price range of $9.00 to $9.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.